Results 41 to 50 of about 63,437 (146)

Aripiprazole once-monthly for the treatment of adult patients with earlier-stage bipolar I disorder: a post hoc analysis of data from a double-blind, placebo-controlled, 52-week randomized withdrawal trial

open access: yesInternational Journal of Bipolar Disorders
Background Increased awareness of the factors contributing to the diagnostic disparities seen in bipolar disorder between individuals of different heritage is needed to achieve equity in diagnosis and treatment.
Karimah S. Bell Lynum   +4 more
doaj   +1 more source

Use of an injection of aripiprazole given once every 2 months (Abilify Asimtufii) in people with bipolar I disorder: a Plain Language Summary of Publication

open access: yesTherapeutic Advances in Psychopharmacology
The purpose of this summary is to explain key findings from a study that included people with bipolar I disorder, as described in two separate articles (see the ‘Further Information’ section for more details).
Roger S. McIntyre   +8 more
doaj   +1 more source

Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries

open access: yesBMC Nephrology
Background Immunoglobulin type A (IgA) nephropathy is the most common primary glomerulonephritis (GN) worldwide with higher rates in East and Pacific Asia compared to North America and Europe.
Omer Zaidi   +4 more
doaj   +1 more source

Wormlike Micellar Solutions, Beyond the Chemical Enhanced Oil Recovery Restrictions

open access: yesFluids, 2019
While traditional oil recovery methods are limited in terms of meeting the overall oil demands, enhanced oil recovery (EOR) techniques are being continually developed to provide a principal portion of our energy demands. Chemical EOR (cEOR) is one of the
Emad Jafari Nodoushan   +3 more
doaj   +1 more source

Quabodepistat in combination with delamanid and bedaquiline in participants with drug-susceptible pulmonary tuberculosis: protocol for a multicenter, phase 2b/c, open-label, randomized, dose-finding trial to evaluate safety and efficacy

open access: yesTrials
Background Delamanid and bedaquiline are two of the most recently developed antituberculosis (TB) drugs that have been extensively studied in patients with multidrug-resistant TB.
Rodney Dawson   +6 more
doaj   +1 more source

Prevalence and epidemiology of depression symptoms among Pakistani students: a systematic review and meta-analysis (2000–2025)

open access: yesCambridge Prisms: Global Mental Health
This systematic review and meta-analysis was a study that enquired into the prevalence and epidemiology of depression in university students in Pakistan, between 2000 and 2025.
Yasmeen Niazi   +3 more
doaj   +1 more source

The relationship between government research funding and the cancer burden in South Korea: implications for prioritising health research

open access: yesHealth Research Policy and Systems, 2019
Background In this study, we aimed to assess health research funding allocation in South Korea by analysing the relationship between government funding and disease burden in South Korea, specifically focusing on cancers.
Ye Lim Jung, Hyoung Sun Yoo, Eun Sun Kim
doaj   +1 more source

Evaluating Optical Coherence Tomography and X-Ray Computed Tomography to Measure Tablet Film Coat Thickness

open access: yesPharmaceutics
Background/Objective: Film coatings are vital components of many pharmaceutical products consumed orally in solid dosage form, and the optimization of the film coating unit operation is critical to the success of these products.
Emily Sanchez   +3 more
doaj   +1 more source

A mixed-methods study protocol for integrating mental health services into primary care for transgender communities through the mhGAP intervention (MenTra) in Pakistan

open access: yesDiscover Public Health
Background Providing mental health services for transgender individuals within primary care is imperative due to the unique challenges they face. Transgender people experience elevated discrimination, stigma, and social exclusion, increasing mental ...
Saima Aleem   +12 more
doaj   +1 more source

An External Control Arm for the Oral Factor XIa Inhibitor Asundexian Phase 2 Trial in Atrial Fibrillation (PACIFIC-AF) Using Electronic Health Records

open access: yesCardiology and Therapy
Introduction The aim of this study was to assess the applicability of an external control arm (ECA) approach in the clinical development of the oral factor XIa inhibitor asundexian for stroke prevention in patients with atrial fibrillation (AF), using ...
Tatsiana Vaitsiakhovich   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy